T90I (p.Thr90Ile) variant of NFKBIA (NF-kappa-B inhibitor alpha)
T90I (p.Thr90Ile) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
T90I (p.Thr90Ile) variant details
- p.Thr90Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.20
- MetaSVM -0.81
- SIFT 0.40
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available